Spravato® Treatment for Depression

FDA-approved esketamine therapy for treatment-resistant depression in a safe, monitored clinical environment.

What is Spravato?

Spravato (esketamine) is a nasal spray used with an antidepressant for treatment-resistant depression.

Our Treatment Suites

Room 1

Room 2

Room 3

Room 4

What to Expect

Check-in & vitals
Spravato administration
2-hour monitored recovery
Safe discharge

Frequently Asked Questions

What is Spravato?
FDA-approved esketamine nasal spray used for treatment-resistant depression.
Do I need monitoring?
Yes, at least 2 hours of clinical supervision is required.
Can I drive after treatment?
No, you must arrange transportation.
Is it safe?
Yes, when administered in a certified medical setting.

Am I Ready for Spravato?

1. Have you been diagnosed with depression?

2. Have you tried 2+ antidepressants?

3. Are symptoms impacting daily life?

Schedule a Consultation